Lexington, MA, United States of America

Elena Getmanova


Average Co-Inventor Count = 7.4

ph-index = 6

Forward Citations = 260(Granted Patents)


Company Filing History:


Years Active: 2010-2021

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Elena Getmanova

Introduction

Elena Getmanova is a prominent inventor based in Lexington, MA (US), known for her significant contributions to the field of biotechnology. With a total of 8 patents to her name, she has made remarkable advancements in the development of polypeptides that interact with vascular endothelial growth factor receptors.

Latest Patents

Her latest patents include "Libraries of modified fibronectin type III tenth domain-containing polypeptides," which focuses on novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides. This patent outlines methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). Additionally, she has developed "Inhibitors of type 2 vascular endothelial growth factor receptors," which also relates to VEGFR-binding polypeptides and their applications in inhibiting VEGF-mediated activities.

Career Highlights

Elena has worked with notable companies such as Bristol-Myers Squibb Company and The General Hospital Corporation. Her work in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in medical research and therapies.

Collaborations

Elena has collaborated with esteemed colleagues, including Lin Sun and Yan Chen, to further her research and development efforts. These collaborations have enhanced her work and expanded the impact of her inventions.

Conclusion

Elena Getmanova's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her innovative work continues to influence advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…